Key result
Concurrent DKA does not affect length of stay, mortality, or readmission in hypertriglyceridemia-induced pancreatitis.
Why the study?
Concurrent diabetic ketoacidosis is highly prevalent in patients with hypertriglyceridemia-induced pancreatitis and may complicate diagnosis, management, and prognosis.
Does concurrent diabetic ketoacidosis affect the clinical course and severity-prediction scores in patients with hypertriglyceridemia-induced pancreatitis?
Population
140 patients with hypertriglyceridemia-induced pancreatitis
Comparison
Hypertriglyceridemia-induced pancreatitis with concurrent DKA vs without DKA
Design
Retrospective cohort study
Follow-up
In-hospital
Authors
Loading...
DKA may inflate severity scores without worsening outcomes in hypertriglyceridemia pancreatitis; leaves open need for adjusted prognostic tools.
Cohort (n=140)
Does concurrent diabetic ketoacidosis affect the clinical course and severity-prediction scores in patients with hypertriglyceridemia-induced pancreatitis?
Concurrent DKA in hypertriglyceridemia-induced pancreatitis artificially inflates severity scores like Ranson and APACHE II without worsening actual clinical outcomes such as mortality or length of stay.
Wang et al. (2017) conducted a cohort in Hypertriglyceridemia-induced pancreatitis (n=140). Concurrent diabetic ketoacidosis vs. No concurrent diabetic ketoacidosis was evaluated on Length of stay, in-hospital mortality, and readmission rate. Concurrent diabetic ketoacidosis (present in 26.4% of patients) did not affect length of stay, in-hospital mortality, or readmission rate in hypertriglyceridemia-induced pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: